Seer/SEER

$1.82

0.54%
-
1D1W1MYTD1YMAX

About Seer

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a gateway to the proteome. The Company’s initial product, the Proteograph Product Suite (Proteograph), is an integrated solution that includes engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. Proteograph leverages its engineered nanoparticle (NP) technology to provide large-scale access to the proteome. Its engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide level, including protein variants. It is focused on adoption of the Proteograph with customers in the proteomics and genomics markets. The Company is initially focused on research applications for the Proteograph product suite and is selling and marketing the Proteograph for research use only (RUO).

Ticker

SEER

Sector

Technology

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Omid Farokhzad

Employees

164

Headquarters

Redwood city, United States
Website
seer.bio

Seer Metrics

BasicAdvanced
$116.16M
Market cap
-
P/E ratio
-$1.43
EPS
-
Beta
-
Dividend rate

What the Analysts think about Seer

Analyst Ratings

Majority rating from 3 analysts.
Hold

Price Targets

Average projection from 1 analysts.
284.62% upside
High $7.00
Low $7.00
$1.82
Current price
$7.00
Average price target

Seer Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-512.19% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$4.1M
2.5%
Net income
$-21M
-10.26%
Profit margin
-512.19%
-12.45%

Seer Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 24.32%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.38
-$0.37
-$0.33
-$0.28
-
Expected
-$0.38
-$0.40
-$0.40
-$0.37
-$0.37
Surprise
-0.65%
-6.33%
-17.5%
-24.32%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Seer stock

Buy or sell Seer stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing